Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	RSV MAT Group - Mother	2	3,557
Total, all-cause mortality	Placebo Group - Mother	1	1,771
Total, all-cause mortality	RSV MAT Group - Infant	20	3,494
Total, all-cause mortality	Placebo Group - Infant	4	1,741
Total, other adverse events	RSV MAT Group - Mother	2,561	3,557
Total, other adverse events	Placebo Group - Mother	1,175	1,771
Total, other adverse events	RSV MAT Group - Infant	2,615	3,494
Total, other adverse events	Placebo Group - Infant	1,293	1,741
Total, serious adverse events	RSV MAT Group - Mother	827	3,557
Total, serious adverse events	Placebo Group - Mother	395	1,771
Total, serious adverse events	RSV MAT Group - Infant	731	3,494
Total, serious adverse events	Placebo Group - Infant	371	1,741

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04605159/event-totals